IPO Trending
APLSME / BSEListed

Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited, established in 2019, is a pharmaceutical company focused on exporting healthcare products worldwide. It offers a wide range of products, including tablets, capsules, sachets, and syrups. These cover various therapeutic areas such as pain relief, antibiotics, antifungals, vitamins, and more. The company manufactures medicines for its own sales as well as on a contract basis, mainly working directly with different marketers. It holds certifications from both Central and State FDA, along with NQA accreditation, and follows Quality Management System standards to maintain product quality. As of July 3, 2025, the company employs 46 permanent staff and 6 contractual workers across different departments.

₹115 - ₹123186.59x sub
Listed Price119.00
Listing Gain-3.25%
Review-Analyst Consensus Verdict

May apply

No review summary is available yet.

Apply
00%
May Apply
00%
Neutral
00%
Avoid
00%
Not Rated
00%
No IPO review records are available for this issue yet.